Q98144046
proposition in the Riksdag 1992-10-15
Press Enter · cited answer in seconds
0 sources
Q98144046
Summary
Q98144046 is a bill[1].
Key Facts
- Q98144046's instance of is recorded as bill[2].
- Q98144046's part of the series is recorded as propositions of the 1992-1993 legislative session of the Riksdag[3].
- Q98144046's language of work or name is recorded as Swedish[4].
- Q98144046 was published on +1992-10-15T00:00:00Z[5].
- Q98144046's main subject is medication[6].
- Q98144046's work available at URL is recorded as http://data.riksdagen.se/dokument/GG0353[7].
- Q98144046's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GG0353[8].
- Q98144046's work available at URL is recorded as http://data.riksdagen.se/fil/C9EDED28-5E57-4D28-A5AB-CF72C0C338DF[9].
- Q98144046's applies to jurisdiction is recorded as Sweden[10].
- Q98144046's legal citation of this text is recorded as Prop. 1992/93:53[11].
- Q98144046's title is recorded as om följdlagstiftning med anledning av den nya läkemedelslagstiftningen m.m.[12].
- Q98144046's cites work is recorded as Q98146337[13].
- Q98144046's cites work is recorded as Q98144103[14].
- Q98144046's cites work is recorded as Q98143494[15].
- Q98144046's cites work is recorded as Q98415691[16].
- Q98144046's cites work is recorded as Q98416337[17].
- Q98144046's cites work is recorded as Q98534163[18].
- Q98144046's maintained by WikiProject is recorded as Project Riksdagen's documents[19].
- Q98144046's copyright status is recorded as public domain[20].
Body
Definition and Type
Q98144046's instance of is recorded as bill[2].